AI assistant
EXELIXIS, INC. — Director's Dealing 2017
Sep 15, 2017
30561_dirs_2017-09-14_86821cf2-aed4-4c7b-87ce-928205489ba3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2017-09-12
Reporting Person: Senner Christopher J. (EVP and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-12 | Common Stock | M | 100000 | $3.66 | Acquired | 202759 | Direct |
| 2017-09-12 | Common Stock | S | 100000 | $26.79 | Disposed | 102759 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-09-12 | Option (right to buy) | $3.66 | M | 100000 | Disposed | 2022-07-14 | Common Stock (100000.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2039 | Indirect |
Footnotes
F1: Includes 20,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 2,361 shares of common stock acquired pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan on April 28, 2017.
F2: Represents 2,039 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of September 12, 2017.
F3: The option, representing the right to purchase a total of 350,000 shares of Exelixis, Inc. common stock, was exercisable as to 182,291 shares on the Transaction Date. Th remainder of the option will vest as to 1/48th of the original number of shares subject to the option on each monthly anniversary of July 15, 2015 grant date.